ConductScience.org, home

Paper10775615

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.

Ikeda K and 6 others. J Virol, 2000. Cited by 132 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. Papers, record 10775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10775615

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.
PubMed
Journal
J Virol
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
132
iCite
Relative citation ratio, by iCite
2.46
iCite
Revised in PubMed
2020-12-22
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ikeda KK
2Wakimoto HH
3Ichikawa TT
4Jhung SS
5Hochberg FHF H
6Louis DND N
7Chiocca EAE A

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Complement System ProteinsMajor topic
GliomaMajor topic
SimplexvirusMajor topic
Adenoviridae
Animals
Brain
Complement Inactivator Proteins
Cyclophosphamide
Elapid Venoms
Female
Gene Transfer Techniques
Genetic Vectors
Herpes Simplex
Humans
Immunosuppressive Agents
Mutation
Rats
Rats, Nude
Virus Activation
Virus Replication

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 CA069246NCI NIH HHSUnited StatesP01CA069246PubMed and NIH
CA 69246NCI NIH HHSUnited StatesP01CA069246PubMed and NIH

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18,212,547A cosmid-based system for constructing mutants of herpes simplex virus type 1.Virology1993https://conductscience.org/library/papers/8212547PubMed
27,511,171Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.J Virol1994https://conductscience.org/library/papers/7511171PubMed
38,186,298Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.Hum Gene Ther1994https://conductscience.org/library/papers/8186298PubMed
48,040,891Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy.J Natl Cancer Inst1994https://conductscience.org/library/papers/8040891PubMed
57,954,393Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.Cancer Res1994https://conductscience.org/library/papers/7954393PubMed
67,954,437Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.Cancer Res1994https://conductscience.org/library/papers/7954437PubMed
77,877,992Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7877992PubMed
87,568,227Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7568227PubMed
97,584,098Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase.Gene Ther1994https://conductscience.org/library/papers/7584098PubMed
107,474,937Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.Lab Invest1995https://conductscience.org/library/papers/7474937PubMed
118,525,509Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.Transplantation1995https://conductscience.org/library/papers/8525509PubMed
128,664,379Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms.Hum Gene Ther1995https://conductscience.org/library/papers/8664379PubMed
138,676,446Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.J Virol1996https://conductscience.org/library/papers/8676446PubMed
148,693,522Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts.Transplantation1996https://conductscience.org/library/papers/8693522PubMed
158,779,679Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.Transplantation1996https://conductscience.org/library/papers/8779679PubMed
168,812,155Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.Exp Neurol1996https://conductscience.org/library/papers/8812155PubMed
178,832,876An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.Science1996https://conductscience.org/library/papers/8832876PubMed
188,895,767A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.Cancer Res1996https://conductscience.org/library/papers/8895767PubMed
198,912,895Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.Exp Neurol1996https://conductscience.org/library/papers/8912895PubMed
208,990,354Apyrase administration prolongs discordant xenograft survival.Transplantation1996https://conductscience.org/library/papers/8990354PubMed

See all 73 references

Cited by88

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
42,652,085Complement-Targeted Therapies in Glioblastoma: A Systematic Review.Biomedicines2026https://conductscience.org/library/papers/42652085PubMed
42,032,342Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment.Nat Cancer2026https://conductscience.org/library/papers/42032342PubMed
40,849,827Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review).Int J Mol Med2025https://conductscience.org/library/papers/40849827PubMed
40,555,086Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges.Semin Immunol2025https://conductscience.org/library/papers/40555086PubMed
40,143,547Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation.Mol Ther2025https://conductscience.org/library/papers/40143547PubMed
39,741,405Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus development.Mol Ther2025https://conductscience.org/library/papers/39741405PubMed
39,710,201Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery.World Neurosurg2025https://conductscience.org/library/papers/39710201PubMed
39,504,364Heterogeneous multiple soft millirobots in three-dimensional lumens.Sci Adv2024https://conductscience.org/library/papers/39504364PubMed
39,239,066Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review.Ann Med Surg (Lond)2024https://conductscience.org/library/papers/39239066PubMed
38,169,820Oncolytic virotherapy in cancer treatment: challenges and optimization prospects.Front Immunol2023https://conductscience.org/library/papers/38169820PubMed
38,150,172Personalizing Oncolytic Immunovirotherapy Approaches.Mol Diagn Ther2024https://conductscience.org/library/papers/38150172PubMed
36,835,091The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles.Int J Mol Sci2023https://conductscience.org/library/papers/36835091PubMed
36,631,681Therapy with oncolytic viruses: progress and challenges.Nat Rev Clin Oncol2023https://conductscience.org/library/papers/36631681PubMed
36,148,235Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.Front Immunol2022https://conductscience.org/library/papers/36148235PubMed
35,062,322Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors.Viruses2022https://conductscience.org/library/papers/35062322PubMed
34,452,439The Multifaceted Role of Macrophages in Oncolytic Virotherapy.Viruses2021https://conductscience.org/library/papers/34452439PubMed
33,981,827Efficient delivery of oncolytic enterovirus by carrier cell line NK-92.Mol Ther Oncolytics2021https://conductscience.org/library/papers/33981827PubMed
32,373,649Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/32373649PubMed
31,312,139Gene Therapy Tools for Brain Diseases.Front Pharmacol2019https://conductscience.org/library/papers/31312139PubMed
31,243,134Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.J Virol2019https://conductscience.org/library/papers/31243134PubMed

See all 88 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10775615

GET https://conductscience.org/api/papers/v1/10775615/references?page=2